Regeneron Pharmaceuticals Signs Build-to-Suit For New HQ in Tarrytown, NY

Regeneron Pharmaceuticals Web Site - December 21, 2006

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today signed a 15-year lease with BioMed Realty Trust, Inc. for a new corporate headquarters and research and development complex to be constructed adjacent to its current facility at the Landmark at Eastview in the Town of Greenburgh in Westchester County, New York. Regeneron also has the option to extend the lease for three additional 5-year periods.

The state-of-the-art complex will consolidate Regeneron’s 440 Tarrytown-based employees, currently scattered among six buildings, into a three-building, interconnected campus. The new facilities will include approximately 194,000 square feet of laboratory and office space in two buildings to be constructed by BioMed Realty Trust over the next two years. The Company will also retain its 27,000 square foot specialized VelociGene® research facility in an existing building at the Landmark at Eastview. The new buildings will incorporate energy efficient technologies along with an open and flexible design that will enhance workplace interactions. Sphere: Related Content